This inventor holds 1 USPTO granted patent. Top assignee: Black Diamond Therapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Giorgio Ottaviani and Cancer-Treatment Innovation.
Introduction
Giorgio Ottaviani is an inventor associated with Riehen, Switzerland. His listed patent concerns a potential approach to cancer treatment using alkyne-substituted quinazoline derivatives.
Latest Patents
Ottaviani is listed on 1 patent: “Method of Treating Cancers with Alkyne Substituted Quinazoline Derivatives.” The patent describes a method involving these compounds for treating cancers.
Career Highlights
Ottaviani is associated with Black Diamond Therapeutics, Inc., a biotechnology company focused on developing medicines for cancer. His listed patent reflects work connected to therapeutic innovation.
Collaborations
Elizabeth Buck and Matthew O’Connor are identified as some of Ottaviani’s coworkers. Their shared company association provides context for his professional environment, though the supplied information does not specify their roles in the patent.
Conclusion
Giorgio Ottaviani’s listed patent and association with Black Diamond Therapeutics, Inc. connect his inventor profile to research into cancer-treatment approaches.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile